Ludwig-Maximilians-Universität München
Penalization Theory and Practice for Cox Models
Biomarker-based phase III clinical trial: Real-world experiences
Estimating effects of time-varying treatments: pitfalls and opportunities
Evaluating and addressing consistency of the evidence in a network metaanalysis
Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator
From model building to validation and back: a plea for robustness
Using network meta-analysis for decision making
Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy
Adaptive designs for confirmatory clinical trials with treatment selection
Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator
Gene signatures as treatment modifiers in clinical trial
Biomarker-based phase II trial designs
Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy
Causal search in high-dimensional settings
Assessing mediation through multiple pathways using natural effect models
The meta-analytic approach to validation of surrogate endpoints
TBD (on meta-regression)
Two folklores: ridge regression versus the lasso
Purposeful penalization of likelihood in small samples
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More